NAMPT and thyroid cancer: Increased circulating visfatin levels and NAMPT tissue overexpression was reported in several malignancies, although discrepancies exist between studies and between tissue and serum compartments (e.g., in thyroid cancer), as seen in Table 6 [10,40].